‌

US Patent 10239944 Compositions and methods related to engineered Fc constructs

Patent 10239944 was granted and assigned to Momenta Pharmaceuticals on March, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Momenta Pharmaceuticals

Current Assignee

Momenta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

102399440

Patent Inventor Names

Laura Rutitzky0

Leona E. Ling0

Carlos J. Bosques0

Daniel Ortiz0

James Meador, III0

James S. Huston0

Jonathan C. Lansing0

Date of Patent

March 26, 2019

Patent Application Number

151414130

Date Filed

April 28, 2016

Patent Citations Received

‌

US Patent 12071482 Compositions and methods related to engineered Fc constructs

‌

US Patent 11623964 Compositions and methods related to engineered Fc constructs

Patent Primary Examiner

‌

Phuong Huynh

Patent abstract

The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10239944 Compositions and methods related to engineered Fc constructs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.